AI is transforming cancer diagnostics with Paige's FDA-approved tool, aiming to improve patient outcomes.

From NVIDIA: 2024-07-10 09:00:12

Generative AI is set to revolutionize cancer diagnostics and patient outcomes in the healthcare industry. Paige, the first FDA-approved tool for cancer diagnosis, is leading the way. Host Noah Kravitz discusses with Paige’s Thomas Fuchs on AI applications in healthcare, aiming to improve precision and care in medicine.

In this episode of NVIDIA’s AI Podcast, Thomas Fuchs delves into how Paige utilizes AI models for cancer detection through visual pattern recognition. Fuchs, also the dean of AI and human health at Mount Sinai, highlights the potential of AI in revolutionizing the medical industry and addressing challenges in cancer detection.

Dotlumen, a member of NVIDIA’s Inception program, is developing AI glasses for visually impaired individuals. CEO Cornel Amariei discusses the assistive technology’s impact on accessibility, emphasizing the importance of innovation in enhancing the daily lives of those with visual impairments.



Read more at NVIDIA: Paige Cofounder Thomas Fuchs’ Diagnosis on Improving Cancer Patient Outcomes With AI